Evaluation of a new beta-adrenoceptor agonist, procaterol, based on metabolic responses in rats.
D000313:Adrenal Medulla / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006912:Hydroxyquinolines / Q000494:pharmacology; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D006912:Hydroxyquinolines; D007328:Insulin; D007773:Lactates; D013806:Theophylline; D000242:Cyclic AMP; D005990:Glycerol